5 research outputs found
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
BACKGROUND: Human enterovirus 71 has emerged as an important pathogen in the Asia Pacific region and it is important to be able to make a rapid and specific diagnosis for outbreak control. Recent Asian strains of Coxsackievirus A16 have changes in the VP1 gene which causes mispriming of widely used primers for human enterovirus 71 specific identification. METHODS: Local strains of Coxsackievirus A16 were sequenced in the VP4 and VP1 genes and using sequence alignment tools, an improved set of primers were designed for specific identification of human enterovirus 71. These primers were evaluated against virus isolates as well as primary clinical specimens. RESULTS: A total of 218 virus strains were tested. All 39 human enterovirus 71 isolates were positive and none of the 38 Coxsackievirus A16, 127 other enteroviruses and 14 prototype flaviviruses and adenoviruses were positive when tested with the new primers. When aliquots of primary specimens known to have yielded human enterovirus 71 were retrospectively tested, we found that within 2 months of collection of the specimens, greater than 90% were positive but that the success rate diminished rapidly to 18% after 2 years storage. CONCLUSIONS: Our new primers will be useful in rapid diagnosis of human enterovirus 71 infection, and can also be used as a screening tool in surveillance programmes for early warning of human enterovirus 71 transmission
Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
Background: Human enterovirus 71 has emerged as an important pathogen in the Asia Pacific
region and it is important to be able to make a rapid and specific diagnosis for outbreak control.
Recent Asian strains of Coxsackievirus A16 have changes in the VP1 gene which causes mispriming
of widely used primers for human enterovirus 71 specific identification.
Methods: Local strains of Coxsackievirus A16 were sequenced in the VP4 and VP1 genes and using
sequence alignment tools, an improved set of primers were designed for specific identification of
human enterovirus 71. These primers were evaluated against virus isolates as well as primary
clinical specimens.
Results: A total of 218 virus strains were tested. All 39 human enterovirus 71 isolates were
positive and none of the 38 Coxsackievirus A16, 127 other enteroviruses and 14 prototype
flaviviruses and adenoviruses were positive when tested with the new primers. When aliquots of
primary specimens known to have yielded human enterovirus 71 were retrospectively tested, we
found that within 2 months of collection of the specimens, greater than 90% were positive but that
the success rate diminished rapidly to 18% after 2 years storage.
Conclusions: Our new primers will be useful in rapid diagnosis of human enterovirus 71 infection,
and can also be used as a screening tool in surveillance programmes for early warning of human
enterovirus 71 transmission
Human Enterovirus 71 Disease in Sarawak, Malaysia: A Prospective Clinical, Virological, and Molecular Epidemiological Study
Background. Human enterovirus (HEV)–71 causes large outbreaks of hand-foot-and-mouth disease with central
nervous system (CNS) complications, but the role of HEV-71 genogroups or dual infection with other viruses
in causing severe disease is unclear.
Methods. We prospectively studied children with suspected HEV-71 (i.e., hand-foot-and-mouth disease, CNS
disease, or both) over 3.5 years, using detailed virological investigation and genogroup analysis of all isolates.
Results. Seven hundred seventy-three children were recruited, 277 of whom were infected with HEV-71,
including 28 who were coinfected with other viruses. Risk factors for CNS disease in HEV-71 included young age,
fever, vomiting, mouth ulcers, breathlessness, cold limbs, and poor urine output. Genogroup analysis for the HEV-
71–infected patients revealed that 168 were infected with genogroup B4, 68 with C1, and 41 with a newly emerged
genogroup, B5. Children with HEV-71 genogroup B4 were less likely to have CNS complications than those with\ud
other genogroups (26 [15%] of 168 vs. 30 [28%] of 109; odds ratio [OR], 0.48; 95% confidence interval [CI],
0.26–0.91; ) and less Pp.0223 likely to be part of a family cluster (12 [7%] of 168 vs. 29 [27%] of 109; OR, 0.21;
95% CI, 0.10–0.46; P ! .0001); children with HEV-71 genogroup B5 were more likely to be part of a family cluster
(OR, 6.26; 95% CI, 2.77–14.18; P ! .0001). Children with HEV-71 and coinfected with another enterovirus or
adenovirus were no more likely to have CNS disease.
Conclusions. Genogroups of HEV-71 may differ with regard to the risk of causing CNS disease and the
association with family clusters. Dual infections are common, and all possible causes should be excluded before
accepting that the first virus identified is the causal agent
Evaluation of Different Clinical Sample Types in Diagnosis of Human Enterovirus 71-Associated Hand-Foot-and-Mouth Diseaseâ–¿
Human enterovirus 71 and coxsackievirus A16 are important causes of hand-foot-and-mouth disease (HFMD). Like other enteroviruses, they can be isolated from a range of sterile and nonsterile sites, but which clinical sample, or combination of samples, is the most useful for laboratory diagnosis of HFMD is not clear. We attempted virus culture for 2,916 samples from 628 of 725 children with HFMD studied over a 3 1/2-year period, which included two large outbreaks. Overall, throat swabs were the single most useful specimen, being positive for any enterovirus for 288 (49%) of 592 patients with a full set of samples. Vesicle swabs were positive for 169 (48%) of 333 patients with vesicles, the yield being greater if two or more vesicles were swabbed. The combination of throat plus vesicle swabs enabled the identification of virus for 224 (67%) of the 333 patients with vesicles; for this patient group, just 27 (8%) extra patients were diagnosed when rectal and ulcer swabs were added. Of 259 patients without vesicles, use of the combination of throat plus rectal swab identified virus for 138 (53%). For 60 patients, virus was isolated from both vesicle and rectal swabs, but for 12 (20%) of these, the isolates differed. Such discordance occurred for just 11 (10%) of 112 patients with virus isolated from vesicle and throat swabs. During large HFMD outbreaks, we suggest collecting swabs from the throat plus one other site: vesicles, if these are present (at least two should be swabbed), or the rectum if there are no vesicles. Vesicle swabs give a high diagnostic yield, with the added advantage of being from a sterile site